SLC12A5 and neurodevelopmental disorder: These findings strongly supported that the alteration of KCC2 function in neurodevelopmental disorders leads to increased excitatory effects of GABA and abnormalities in social behavior and memory retention (Moore et al., 2019), a disruption that can be corrected through combination therapy in autism models.